Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Mengzhu Wei

Showing results (1-10 of 4) with videos related to

Pageof 1
Sort By:
Journal of Autoimmunity|December 18, 2025
Circadian clock genes: Potential therapeutic targets for autoimmune diseasesTian Tian, Lulu Rao, Mengzhu Wei, et al.
Cellular Signalling|March 4, 2025
Paeoniflorin-6'-O-benzene sulfonate inhibits keratinocyte proliferation by restoring GRK2-JAK1 colocalization in mouse model of psoriasisTian Tian, Mengzhu Wei, Yanling Guan, et al.
Infectious Agents and Cancer|November 14, 2023
IGFBP2 drives epithelial-mesenchymal transition in hepatocellular carcinoma via activating the Wnt/β-catenin pathwayXiu Chen, Yu Zhang, Pingping Zhang, et al.
Cellular Immunology|February 7, 2024
The research progression of direct NLRP3 inhibitors to treat inflammatory disordersXiu Chen, Pingping Zhang, Yu Zhang, et al.
Pageof 1

Showing results (1-10 of 4) with videos related to

Sort By:
Pageof 1
Journal of Autoimmunity|December 18, 2025
Circadian clock genes: Potential therapeutic targets for autoimmune diseasesTian Tian, Lulu Rao, Mengzhu Wei, et al.
Cellular Signalling|March 4, 2025
Paeoniflorin-6'-O-benzene sulfonate inhibits keratinocyte proliferation by restoring GRK2-JAK1 colocalization in mouse model of psoriasisTian Tian, Mengzhu Wei, Yanling Guan, et al.
Infectious Agents and Cancer|November 14, 2023
IGFBP2 drives epithelial-mesenchymal transition in hepatocellular carcinoma via activating the Wnt/β-catenin pathwayXiu Chen, Yu Zhang, Pingping Zhang, et al.
Cellular Immunology|February 7, 2024
The research progression of direct NLRP3 inhibitors to treat inflammatory disordersXiu Chen, Pingping Zhang, Yu Zhang, et al.
Pageof 1